title: Is iPLA2β a Novel Target for the Development of New Strategies to Alleviate Inflammatory Bowel Disease?
authors.affiliation: Department of Molecular and Biomedical Sciences, Jožef Stefan Institute, Jamova 39, 1000, Ljubljana, Slovenia. toni.petan@ijs.si.
authors.forename: Toni
authors.initials: T
authors.lastname: Petan
authors.affiliation: Department of Molecular and Biomedical Sciences, Jožef Stefan Institute, Jamova 39, 1000, Ljubljana, Slovenia. igor.krizaj@ijs.si.|Department of Chemistry and Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, 1000, Ljubljana, Slovenia. igor.krizaj@ijs.si.
authors.forename: Igor
authors.initials: I
authors.lastname: Križaj
mesh_terms: D000818:Animals; D003092:Colitis / Q000139:chemically induced*; D054522:Group VI Phospholipases A2 / Q000378:metabolism*; D006801:Humans; D008297:Male
chemical_list: D054522:Group VI Phospholipases A2